Home>
US Stocks>
Lifecore Biomedical Inc

Lifecore Biomedical Inc share price today

(LFCR)

Lifecore Biomedical Inc share price is $7.18 & ₹608.02 as on 10 Dec 2024, 2.30 'hrs' IST

$7.18

▲

0.04

(0.49%)

Market is closed - opens 8 PM, 10 Dec 2024

View live Lifecore Biomedical Inc share price in Dollar and Rupees. Guide to invest in Lifecore Biomedical Inc from India. Also see the sentimental analysis on Indian investors investing in Lifecore Biomedical Inc. Get details on the Indian mutual funds that are investing in Lifecore Biomedical Inc. Get Analyst recommendations and forecasts along with all the Lifecore Biomedical Inc's financials.

Lifecore Biomedical Inc share price movements

$7.14
$7.74
$7.18
0.56%
Downside
Day's Volatility :7.75%
Upside
7.24%
$3.68
$8.90
$7.18
48.76%
Downside
52 Weeks Volatility :58.66%
Upside
19.33%

Lifecore Biomedical Inc Returns

Period	Lifecore Biomedical Inc	Index (Russel 2000)
3 Months	48.55%	0.0%
6 Months	27.71%	0.0%
1 Year	21.86%	0.0%
3 Years	-23.75%	-20.3%

Lifecore Biomedical Inc Key Statistics

in dollars & INR

Previous Close	$7.145
Open	$7.32
Today's High	$7.74
Today's Low	$7.14
Market Capitalization	$280.3M
Today's Volume	$109.5K
52 Week High	$8.9
52 Week Low	$3.6793
Revenue TTM	$128.4M
EBITDA	$-674.0K
Earnings Per Share (EPS)	$0.13
PE Ratio	58.54
Profit Margin	5.09%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	17.29%

How to invest in Lifecore Biomedical Inc from India?

It is very easy for Indian residents to invest directly in Lifecore Biomedical Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lifecore Biomedical Inc stock in both rupees (INR) and dollars (USD). Search for Lifecore Biomedical Inc or LFCR on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lifecore Biomedical Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lifecore Biomedical Inc shares which would translate to 0.118 fractional shares of Lifecore Biomedical Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Lifecore Biomedical Inc

-57%

Period: Sep 10, 2024 to Dec 9, 2024. Change in 30 Days versus previous period

Search volume for Lifecore Biomedical Inc on INDmoney from India has reduced in the last 30 days as on Dec 10, 2024. -57% less investors are searching Lifecore Biomedical Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Lifecore Biomedical Inc

Wynnefield Capital Inc
13.36%
Legion Partners Asset Management, LLC
8.06%
Greenhaven Road Investment Management, L.P.
6.05%
22NW, LP
4.77%
BlackRock Inc
3.94%
325 Capital LLC
3.72%

Analyst Recommendation on Lifecore Biomedical Inc

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Lifecore Biomedical Inc(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Lifecore Biomedical Inc

What analysts predicted

Upside of 11.42%

Current:

$7.18

Target:

$8.00

Insights on Lifecore Biomedical Inc

Price Movement
In the last 3 months, LFCR stock has moved up by 51.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 37.88M → 24.70M (in $), with an average decrease of 34.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.08M → -16.23M (in $), with an average decrease of 129.1% per quarter
LFCR vs CTLT (1 yr)
In the last 1 year, Catalent, Inc. has given 67.1% return, outperforming this stock by 52.4%
Price to Sales
ForLFCR every $1 of sales, investors are willing to pay $1.7, whereas for Catalent, Inc., the investors are paying $2.5 for every $1 of sales.

Lifecore Biomedical Inc Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$557.6M	↑ 6.36%
Net Income	$2.1M	↓ 91.45%
Net Profit Margin	0.38%	↓ 4.36%

	FY20	Y/Y Change
Revenue	$590.4M	↑ 5.88%
Net Income	$-38.2M	↓ 1899.76%
Net Profit Margin	-6.47%	↓ 6.85%

	FY21	Y/Y Change
Revenue	$544.2M	↓ 7.83%
Net Income	$-32.7M	↓ 14.47%
Net Profit Margin	-6.0%	↑ 0.47%

	FY22	Y/Y Change
Revenue	$185.8M	↓ 65.86%
Net Income	$-97.4M	↑ 198.27%
Net Profit Margin	-52.44%	↓ 46.44%

	FY23	Y/Y Change
Revenue	$185.8M	↑ 0.0%
Net Income	$-46.1M	↓ 52.7%
Net Profit Margin	-24.8%	↑ 27.64%

	FY24	Y/Y Change
Revenue	$128.3M	↓ 30.96%
Net Income	$12.0M	↓ 126.07%
Net Profit Margin	9.37%	↑ 34.17%

	Q2 FY23	Q/Q Change
Revenue	$27.6M	↓ 42.05%
Net Income	$-15.5M	↓ 57.61%
Net Profit Margin	-56.02%	↑ 20.56%

	Q3 FY23	Q/Q Change
Revenue	$24.5M	↓ 11.15%
Net Income	$-10.8M	↓ 30.44%
Net Profit Margin	-43.85%	↑ 12.17%

	Q4 FY23	Q/Q Change
Revenue	$30.2M	↑ 22.95%
Net Income	$14.2M	↓ 232.21%
Net Profit Margin	47.16%	↑ 91.01%

	Q1 FY24	Q/Q Change
Revenue	$31.5M	↑ 4.63%
Net Income	$-36.1M	↓ 354.11%
Net Profit Margin	-114.53%	↓ 161.69%

	Q2 FY24	Q/Q Change
Revenue	$37.9M	↑ 20.1%
Net Income	$-7.1M	↓ 80.4%
Net Profit Margin	-18.7%	↑ 95.83%

	Q3 FY24	Q/Q Change
Revenue	$24.7M	↓ 34.79%
Net Income	$-16.2M	↑ 129.14%
Net Profit Margin	-65.7%	↓ 47.0%

	FY19	Y/Y Change
Total Assets	$519.1M	↑ 28.26%
Total Liabilities	$248.9M	↑ 63.63%

	FY20	Y/Y Change
Total Assets	$541.3M	↑ 4.28%
Total Liabilities	$310.3M	↑ 24.63%

	FY21	Y/Y Change
Total Assets	$502.9M	↓ 7.09%
Total Liabilities	$300.1M	↓ 3.26%

	FY22	Y/Y Change
Total Assets	$295.2M	↓ 41.31%
Total Liabilities	$187.2M	↓ 37.62%

	FY23	Y/Y Change
Total Assets	$295.4M	↑ 0.09%
Total Liabilities	$187.3M	↑ 0.04%

	FY24	Y/Y Change
Total Assets	$273.7M	↓ 7.36%
Total Liabilities	$219.8M	↑ 17.35%

	Q2 FY23	Q/Q Change
Total Assets	$236.2M	↓ 17.37%
Total Liabilities	$201.9M	↑ 6.91%

	Q3 FY23	Q/Q Change
Total Assets	$245.6M	↑ 4.01%
Total Liabilities	$259.2M	↑ 28.34%

	Q4 FY23	Q/Q Change
Total Assets	$245.8M	↑ 0.08%
Total Liabilities	$244.4M	↓ 5.7%

	Q1 FY24	Q/Q Change
Total Assets	$255.2M	↑ 3.8%
Total Liabilities	$257.0M	↑ 5.15%

	Q2 FY24	Q/Q Change
Total Assets	$273.7M	↑ 7.27%
Total Liabilities	$219.8M	↓ 14.47%

	Q3 FY24	Q/Q Change
Total Assets	$246.8M	↓ 9.82%
Total Liabilities	$207.3M	↓ 5.68%

	FY19	Y/Y Change
Operating Cash Flow	$16.0M	↓ 19.01%
Investing Cash Flow	$-96.8M	-
Financing Cash Flow	$79.0M	↑ 494.54%

	FY20	Y/Y Change
Operating Cash Flow	$-17.0M	↓ 206.37%
Investing Cash Flow	$-23.9M	↓ 75.32%
Financing Cash Flow	$40.0M	↓ 49.36%

	FY21	Y/Y Change
Operating Cash Flow	$15.0M	↓ 188.12%
Investing Cash Flow	$-10.9M	↓ 54.55%
Financing Cash Flow	$-3.4M	↓ 108.54%

	FY22	Y/Y Change
Operating Cash Flow	$-24.4M	↓ 262.48%
Investing Cash Flow	$81.8M	↓ 853.21%
Financing Cash Flow	$-57.0M	↑ 1567.77%

	FY23	Y/Y Change
Operating Cash Flow	$-24.4M	↑ 0.0%
Investing Cash Flow	$-4.2M	↓ 105.08%
Financing Cash Flow	$-57.0M	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.7M	↓ 35345.42%
Investing Cash Flow	$6.4M	↓ 296.56%
Financing Cash Flow	$6.1M	↓ 68.22%

Lifecore Biomedical Inc Technicals Summary

Sell

Neutral

Buy

Lifecore Biomedical Inc is currently in a neutral trading position according to technical analysis indicators.

Lifecore Biomedical Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lifecore Biomedical Inc	9.94%	27.71%	21.86%	-23.75%	-37.75%
Neurocrine Biosciences Inc.	-0.59%	-5.05%	6.67%	53.4%	13.45%
Haleon Plc Spon Ads	2.31%	16.95%	18.37%	31.31%	31.31%
Zoetis Inc.	-0.78%	-2.11%	-7.75%	-24.78%	40.57%
Viatris Inc.	-1.53%	21.15%	31.13%	2.71%	-21.11%
Catalent, Inc.	4.47%	11.31%	63.78%	-50.26%	18.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lifecore Biomedical Inc	58.54	58.54	3.51	0.41	0.17	-0.02	NA	-0.13
Neurocrine Biosciences Inc.	33.98	33.98	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.36	29.36	1.74	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.98	32.98	2.44	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	514.17	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lifecore Biomedical Inc	Sell	$280.3M	-37.75%	58.54	5.09%
Neurocrine Biosciences Inc.	Buy	$12.9B	13.45%	33.98	17.21%
Haleon Plc Spon Ads	Buy	$43.8B	31.31%	29.36	10.75%
Zoetis Inc.	Buy	$79.1B	40.57%	32.98	26.55%
Viatris Inc.	Hold	$15.1B	-21.11%	224.4	-5.87%
Catalent, Inc.	Hold	$11.2B	18.91%	211.02	-9.34%

About Lifecore Biomedical Inc

landec corporation (nasdaq:lndc) is a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets. apio, landec's food business, is the leader in branded, packaged fresh vegetables in north america, utilizing its proprietary breatheway® packaging technology to naturally extend the shelf life of fresh produce. apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the eat smart® brand to consumers through club and retail grocery stores. lifecore biomedical, landec's biomaterial business, is a fully integrated contract development and manufacturing organization (cdmo) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for fda regulated medical devices and drugs to customers for applications in a wide array of markets including ophthalmic, orthopedic and oncology. for more information abo

Organization	Lifecore Biomedical Inc
Employees	524
CEO	Mr. Paul Josephs
Industry	Healthcare

Management People of Lifecore Biomedical Inc

Name	Title
Mr. Paul Josephs	President, CEO & Director
Mr. James G. Hall	Advisor
Mr. Ryan D. Lake CPA	CFO & Secretary
Mr. Aaron Perlitsh	Director of Internal Audit & Chief Compliance Officer
Mr. Darren M. Hieber	Senior Vice President of Corporate Development & Partnerships
Ms. Brikkelle Thompson	Senior Vice President of Human Resources
Ms. Jackie Q. Klecker	Executive VP, Quality and Development Services & GM
Mr. Matt Augustson	Senior Vice President of Information Technology
Dr. Albert D. Bolles Ph.D.	President of Curation Foods, Inc.
Mr. Parker K. Javid	Vice President

Important FAQs about investing in Lifecore Biomedical Inc from India :

What is Lifecore Biomedical Inc share price today?

Lifecore Biomedical Inc (LFCR) share price today is $7.18.

Can Indians buy Lifecore Biomedical Inc shares?

Yes, Indians can invest in the Lifecore Biomedical Inc (LFCR) from India.

With INDmoney, you can buy Lifecore Biomedical Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lifecore Biomedical Inc at zero transaction cost.

How can I buy Lifecore Biomedical Inc shares from India?

It is very easy to buy Lifecore Biomedical Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lifecore Biomedical Inc be purchased?

Yes, you can buy fractional shares of Lifecore Biomedical Inc with INDmoney app.

What are the documents required to start investing in Lifecore Biomedical Inc stocks?

To start investing in Lifecore Biomedical Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.